Table 3.

Effects of the MELD score and the follow-up period on the absolute counts of lymphocyte subpopulations following liver transplantation.

Absolute counts	LmLf (n = 18)	HmLf (n = 13)	LmSf (n = 20)	HmSf (n = 15)
T	964.72 ± 437.14**	731.62 ± 388.89*	590.60 ± 335.74	336.40 ± 429.80
TCD4	479.61 ± 236.73*	365.69 ± 302.93*	289.95 ± 201.47	153.00 ± 239.11
TCD8	485.22 ± 231.35**	365.92 ± 135.42*	300.65 ± 161.45	183.47 ± 201.86
B	114.44 ± 124.70	72.15 ± 65.96	70.25 ± 67.68	27.80 ± 53.15
NK	173.11 ± 71.15*	151.54 ± 94.55	118.60 ± 89.08	79.67 ± 99.06

MELD, model for end-stage liver disease; T, CD3⁺ T cells; TCD4, CD3⁺ CD4⁺ T cells; TCD8, CD3⁺ CD8⁺ T cells; B, CD19⁺ B cells; NK, CD56⁺ CD16⁺ natural killer cells; Lm, low MELD score; Hm, high MELD score; Sf, short-term follow-up; Lf, long-term follow-up.

HmLf vs. HmSf, LmSf vs. HmSf,

^*p < 0.05,

^**p < 0.01.